Publications by authors named "Thierry Rème"

50Publications

Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry.

Cytometry B Clin Cytom 2018 05 19;94(3):484-492. Epub 2017 Sep 19.

Institute of Human Genetics, UMR 9002 CNRS, University of Montpellier, Montpellier, F-34396, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21590DOI Listing
May 2018

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

Front Neurol 2015 24;6:181. Epub 2015 Aug 24.

Laboratoire de Biochimie-Protéomique Clinique, Institute for Regenerative Medicine and Biotherapy (IRMB), CHU de Montpellier and Université Montpellier , Montpellier , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2015.00181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547499PMC
September 2015

GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.

PLoS Comput Biol 2015 Jan 29;11(1):e1004077. Epub 2015 Jan 29.

U1040, INSERM, Montpellier, France; Department of Biological Hematology, CHU Montpellier, Montpellier, France; UFR Médecine, Université MONTPELLIER 1, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pcbi.1004077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310610PMC
January 2015

In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model.

Gut 2014 Sep 23;63(9):1490-500. Epub 2013 Oct 23.

INSERM U1040, Montpellier, France Université Montpellier 1, Montpellier, France CHU Saint Eloi, Institute of Research in Biotherapy, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2013-304623DOI Listing
September 2014

DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.

Cell Cycle 2013 Sep 9;12(17):2760-73. Epub 2013 Aug 9.

CHU Montpellier; Institute of Research in Biotherapy; Montpellier, France; INSERM; U1040; Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.25951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899190PMC
September 2013

Modeling risk stratification in human cancer.

Bioinformatics 2013 May 14;29(9):1149-57. Epub 2013 Mar 14.

INSERM-UM1, U1040, Institut de Recherche en Biothérapie, 34295 Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btt124DOI Listing
May 2013

Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors.

Mol Cancer Ther 2012 Dec 18;11(12):2685-92. Epub 2012 Oct 18.

CHU Montpellier, Institute of Research in Biotherapy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0721DOI Listing
December 2012

The role of fluorescence in situ hybridization and gene expression profiling in myeloma risk stratification.

Srp Arh Celok Lek 2011 Dec;139 Suppl 2:84-9

Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2298/sarh11s2084hDOI Listing
December 2011

Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine.

Clin Cancer Res 2011 Dec 10;17(23):7240-7. Epub 2011 Oct 10.

Medizinische Klinik V, Universitätsklinikum Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1628DOI Listing
December 2011

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration.

Blood 2011 Jan 19;117(4):1280-90. Epub 2010 Nov 19.

Centre Hospitalier Universitaire Montpellier, Institute of Research in Biotherapy, Av. Augustin Fliche, Montpellier cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-04-279760DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009699PMC
January 2011

MYEOV is a prognostic factor in multiple myeloma.

Exp Hematol 2010 Dec 18;38(12):1189-1198.e3. Epub 2010 Sep 18.

CHU Montpellier, Institute of Research in Biotherapy, Hopital St Eloi, Av. Augustin Fliche, Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2010.09.002DOI Listing
December 2010

Total fertilization failure and molecular abnormalities in metaphase II oocytes.

Reprod Biomed Online 2008 Dec;17(6):772-81

CHU Montpellier, IRB, Institute for Research in Biotherapy, Hôpital Saint-Eloi, Montpellier, F 34295, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1472-6483(10)60404-xDOI Listing
December 2008

CD200: a putative therapeutic target in cancer.

Biochem Biophys Res Commun 2008 Feb 4;366(1):117-22. Epub 2007 Dec 4.

CHU Montpellier, Hopital St Eloi, Institut de Recherches en Biothérapie, Av Augustin Fliche, 34285 Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.11.103DOI Listing
February 2008

A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

Stem Cells 2007 Apr 4;25(4):961-73. Epub 2007 Jan 4.

Centre Hospitalier Universitaire de Montpellier, Institute for Research in Biotherapy, Hôpital Saint-Eloi, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1634/stemcells.2006-0352
Publisher Site
http://dx.doi.org/10.1634/stemcells.2006-0352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906587PMC
April 2007

CD200 is a new prognostic factor in multiple myeloma.

Blood 2006 Dec 31;108(13):4194-7. Epub 2006 Aug 31.

Centre Hospitalier Universitaire (CHU) Montpellier, Department of Hematology and Clinical Oncology and Institute of Research in Biotherapy, Montpellier, France.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/108/13/4194.full.pdf
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2006-06-02
Publisher Site
http://dx.doi.org/10.1182/blood-2006-06-029355DOI Listing
December 2006

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.

Blood 2004 Apr 4;103(8):3148-57. Epub 2003 Dec 4.

Institut National de la Santé et de la Recherche Médicale U475 and Unité de Thérapie Cellulaire, Centre Hospitalier Universitaire Montpellier, Hôpital St Eloi, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-06-1984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387243PMC
April 2004